Activist 13D/13G Filings - Concert Pharmaceuticals, Inc. (CNCE)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company‚Äôs equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto 0, 1, Next
Reported
DateTime
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportFiling
2023-02-14
4:45 pm
Purchase
13GConcert Pharmaceuticals, Inc.
CNCE
RA CAPITAL MANAGEMENT L.P.5,199,746
9.99%
1,689,643increase
(+48.14%)
View
2023-02-14
2:35 pm
Sale
13GConcert Pharmaceuticals, Inc.
CNCE
PERCEPTIVE ADVISORS LLC1,800,000
3.6%
-350,641decrease
(-16.30%)
View
2023-02-13
6:02 pm
Purchase
13GConcert Pharmaceuticals, Inc.
CNCE
BIOTECHNOLOGY VALUE FUND L P4,917,774
9.99%
1,321,017increase
(+36.73%)
View
2023-02-13
09:25 am
Unchanged
13GConcert Pharmaceuticals, Inc.
CNCE
Kynam Capital Management LP4,420,349
9.2%
0
(Unchanged)
View
2023-02-10
3:51 pm
Purchase
13GConcert Pharmaceuticals, Inc.
CNCE
Kynam Capital Management LP4,420,349
9.2%
4,420,349increase
(New Position)
View
2022-02-14
4:11 pm
Purchase
13GConcert Pharmaceuticals, Inc.
CNCE
RA CAPITAL MANAGEMENT L.P.3,510,103
9.99%
1,686,583increase
(+92.49%)
View
2022-02-14
3:46 pm
Unchanged
13GConcert Pharmaceuticals, Inc.
CNCE
PERCEPTIVE ADVISORS LLC2,150,641
6.2%
0
(Unchanged)
View
2022-01-13
10:20 am
Sale
13GConcert Pharmaceuticals, Inc.
CNCE
BANK OF AMERICA CORP
BAC
1,007,258
2.9%
-870,960decrease
(-46.37%)
View
2021-11-15
4:58 pm
Purchase
13GConcert Pharmaceuticals, Inc.
CNCE
BIOTECHNOLOGY VALUE FUND L P3,596,757
9.99%
3,596,757increase
(New Position)
View
2021-07-12
08:29 am
Sale
13GConcert Pharmaceuticals, Inc.
CNCE
BlackRock Inc.
BLK
670,035
2.1%
-1,534,474decrease
(-69.61%)
View
2021-02-16
4:39 pm
Purchase
13GConcert Pharmaceuticals, Inc.
CNCE
RA CAPITAL MANAGEMENT L.P.1,823,520
5.9%
1,823,520increase
(New Position)
View
2021-02-16
3:30 pm
Unchanged
13GConcert Pharmaceuticals, Inc.
CNCE
PERCEPTIVE ADVISORS LLC2,150,641
7%
0
(Unchanged)
View
2021-02-12
4:38 pm
Sale
13GConcert Pharmaceuticals, Inc.
CNCE
DIMENSIONAL FUND ADVISORS LP1,079,170
3.5%
-129,831decrease
(-10.74%)
View
2021-02-09
4:41 pm
Sale
13GConcert Pharmaceuticals, Inc.
CNCE
INGALLS & SNYDER LLC1,396,003
4.55%
-68,709decrease
(-4.69%)
View
2021-02-08
5:06 pm
Purchase
13GConcert Pharmaceuticals, Inc.
CNCE
BANK OF AMERICA CORP
BAC
1,878,218
6.1%
67,012increase
(+3.70%)
View
2021-02-02
2:56 pm
Purchase
13GConcert Pharmaceuticals, Inc.
CNCE
BlackRock Inc.
BLK
2,204,509
7.2%
735,550increase
(+50.07%)
View
2020-02-14
5:01 pm
Unchanged
13GConcert Pharmaceuticals, Inc.
CNCE
GSK plc1,179,941
4.1%
0
(Unchanged)
View
2020-02-14
4:28 pm
Purchase
13GConcert Pharmaceuticals, Inc.
CNCE
PERCEPTIVE ADVISORS LLC2,150,641
9%
276,862increase
(+14.78%)
View
2020-02-14
3:13 pm
Sale
13GConcert Pharmaceuticals, Inc.
CNCE
BIOTECHNOLOGY VALUE FUND L P0
0%
-1,408,187decrease
(Position Closed)
View
2020-02-14
1:30 pm
Sale
13GConcert Pharmaceuticals, Inc.
CNCE
RTW INVESTMENTS LP0
0%
-1,811,662decrease
(Position Closed)
View
Goto 0, 1, Next